Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2005 / Cilt: 39 - Sayı: 2

Our therapeutic approach to TEN: the retrospective evaluation of rotational and combination therapies

TEN'de tedavi yaklaşımımız: Rotasyonel ve kombine tedavilerin retrospektif incelenmesi

Pages
115–120
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, the survival of all TEN patients except one with decompansated renal failure with these therapeutic regimens provides evidence for the efficacy of combined and rotational therapies of corticosteroids, IVIgs and plasmapheresis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and design: Toxic epidermal necrolysis (TEN) is a severe, progressive disease most commonly induced by drugs and characterized by the sudden onset of skin necrolysis.
📊
Key Findings & Data:Material and Methods: We retrospectively evaluated a total of 8 TEN cases followed up by our department since 2000 and documented the demographic features, clinical presentation of these cases and their response to combination and rotational therapies with.pulse steroids, IVIgs and plasmapheresis.
💡
Conclusion & Impact:Conclusion: In conclusion, the survival of all TEN patients except one with decompansated renal failure with these therapeutic regimens provides evidence for the efficacy of combined and rotational therapies of corticosteroids, IVIgs and plasmapheresis.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and design: Toxic epidermal necrolysis (TEN) is a severe, progressive disease most commonly induced by drugs and characterized by the sudden onset of skin necrolysis. It is frequently associated with systemic involvement and has a high mortality. No standard therapeutic regimen exists for the medical therapy of TEN. Material and Methods: We retrospectively evaluated a total of 8 TEN cases followed up by our department since 2000 and documented the demographic features, clinical presentation of these cases and their response to combination and rotational therapies with.pulse steroids, IVIgs and plasmapheresis. Results: The most frequently culprit drug was found to be phenytoin followed by ciprofloxaciline and salicilic acid. Three of the cases were diagnosed as "Overlap SJS-TEN", three as "TEN with spots" and two as "TEN without spots". The therapy of five of 8 patients treated with high doses of corticosteroids were combined with IVIgs (0.6-0.7 g/kg/d for 5 days) due to the aggressive course of disease. Plasmapheresis was also performed to three of five cases who received IVIgs. All five cases who receieved the combined immun-suppressive drugs developed sepsis that was effectively controlled with antibiotics. Conclusion: In conclusion, the survival of all TEN patients except one with decompansated renal failure with these therapeutic regimens provides evidence for the efficacy of combined and rotational therapies of corticosteroids, IVIgs and plasmapheresis. We recommend that these therapies should be administered by an experienced team with a multidisciplinary approach.

Özet

Toksik epidermal nekrolizis (TEN) sıklıkla ilaçlarla tetiklenen ve deride ani nekrozla karakterize şiddetli ve ilerleyici bir hastalıktır.Sıklıkla sistemik tutulum görülür ve yüksek mortaliteye sahiptir.TEN'in medikal tedavisinde standart bir tedavi rejimi bulunmamaktadır. Kliniğimizde 2000 yılından beri takip edilmiş olan toplam 8 TEN olgusunu retrospektif olarak değerlendirdik ve olguların demografik özelliklerini, klinik görünümlerini ve pulse steroid, Intravenöz immunoglobulinler (IVIg) ve plazmaferez ile kombine ve rotasyona! tedavilere cevaplarını sunduk. En sık saptanan sorumlu ilaç fenitoin olup takiben siprofloksasin ve salisilik asit bulundu. Olguların üçüne "Overlap SJS-TEN", üçüne "Spotlu TEN" ve ikisine "Spotsuz TEN " tanısı konuldu.Hastalığın şiddetli seyrinden dolayı yüksek doz kortikosteroid ile tedavi gören 8 olgunun beşinde tedaviye IVIg (0.6-0.7 g/kg/g 5 gün boyunca) eklendi. IVIg alan beş olgunun üçüne plazmaferez de uygulandı. Kombine tedavi gören beş olgunun hepsinde antibiyotiklerle kontrol altına alınabilen sepsis tablosu gelişti. Sonuç olarak, uyguladığımız tedavi rejimleri ile dekompanse renal yetmezliği olan bir olgu dışındaki tüm TEN olgularının iyileşmesi, kortikosteroid, IVIg ve plazmaferezle kombine ve rotasyonal tedavilerin etkinliğini göstermektedir. Bu tedavilerin deneyimli bir ekip tarafından multidisipliner bir yaklaşımla uygulanmasını öneriyoruz.

🔖

Cite This Article

BAŞKAN, B. E., TUNALI, Ş., KARADOĞAN, K. S., SARICAOĞLU, H., YILMAZ, E. (2022). Our therapeutic approach to TEN: the retrospective evaluation of rotational and combination therapies. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 39 - Sayı: 2, 115–120. https://ajindex.com/articles/622206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Roujeau JC, Stern RS: Severe adverse reactions to drugs. N Engl J Med 1994; 331: 1 272-85
  2. Becker DS: Toxic epidermal necrolysis. Lancet 1 998; 351:1417-20
  3. Trautmann A, Klein CE, Kampgen E, Bracker EB: Severe bullous drug reactions treated successfully with cyclophosphamide. Br J Dermatol 1998; 139: 1127- 28
  4. Arevalo JM, Lorente JA, Gozales-Herrada C, JimenezReyes J: Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma 2000;48: 473-78
  5. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Bo- udeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpied B, Pilorget A, Bocquet H, Brun-Buisson C, Revuz J: Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998; 352: 1586-89
  6. Egan CA, Grant WJ, Morris ES, Daffle KR, Zone dermal necrolysis. J Am Acad Dermatol 1999; 40:458-61
  7. Prins C, Kerdel FF, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN: Treatment of toxic epidermal necrolysis with high dose intravenous immunoglobulins. Arch Dermatol 2003; 139: 26-32
  8. Patterson R, Dykewicz MS, Gonzalzles A, Grammer LC, Green D, Greenberger PA, McGrath KG, Walker CL: Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest 1990; 98: 331-36
  9. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129: 92-96
  10. Avakian R, Flowers FP, Araujo AEO, Ramos-Caro FA: Toxic epidermal necrolysis: a review. J Am Acad Der¬matol 1991;25:69-79
  11. Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ: Toxic epidermal necrolysis: a step forward in treatment. JAMA 1987; 257:2171-5
  12. Halebian PH, Corder VJ, Herndon D: A burn center experience with toxic epidermal necrolysis. J Burn Care Rehabil 1983; 4: 1 76-83
  13. Revuz J, Roujeau JC, Guillaume JC ve ark: Treatment of toxic epidermal necrolysis: Creteil's experience. Arch Dermatol 1987; 1 23: 1156-8
  14. Halebian PH, Corder VJ, Madden MR, Finkelstein JL, Shires GT: Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986; 204: 503-51 2
  15. Kim PS, Goldfarb IW, Graisford JC, Slater H: Stevens-Johnson syndrome and toxic epidermal necrolsis: a pathophysiologic review with recommendations for a treatment protocol. J Burn Care Rehabil 1983;4:91-100
  16. Tegelberg-Stassen MJ, van Vloten WA, Baart de la Faille: Mana